{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:20:50Z","timestamp":1794021650736,"version":"4.8.0"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"4","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Receptor activator of nuclear factor-\u03baB (NF-\u03baB) ligand (RANKL) has emerged as a major mediator of bone resorption, commonly associated with cancer and other chronic inflammatory diseases. Inhibitors of RANKL signaling thus have potential in preventing bone loss. In the present report, the potential of zerumbone, a sesquiterpene derived from subtropical ginger, to modulate osteoclastogenesis induced by RANKL and breast cancer was examined. We found that zerumbone inhibited RANKL-induced NF-\u03baB activation in mouse monocyte, an osteoclast precursor cell, through inhibition of activation of I\u03baB\u03b1 kinase, I\u03baB\u03b1 phosphorylation, and I\u03baB\u03b1 degradation. Zerumbone also suppressed RANKL-induced differentiation of these cells to osteoclasts. This sesquiterpene also inhibited the osteoclast formation induced by human breast tumor cells and by multiple myeloma cells. Finally, we examined whether zerumbone could prevent human breast cancer\u2013induced bone loss in animals. We found that zerumbone decreased osteolysis in a dose-dependent manner in MDA-MB-231 breast cancer tumor-bearing athymic nude mice. These results indicate that zerumbone is an effective blocker of RANKL-induced NF-\u03baB activation and of osteoclastogenesis induced by RANKL and tumor cells, suggesting its potential as a therapeutic agent for osteoporosis and cancer-associated bone loss. [Cancer Res 2009;69(4):1477\u201384]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-3249","type":"journal-article","created":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T23:04:00Z","timestamp":1233702240000},"page":"1477-1484","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Zerumbone Abolishes RANKL-Induced NF-\u03baB Activation, Inhibits Osteoclastogenesis, and Suppresses Human Breast Cancer\u2013Induced Bone Loss in Athymic Nude Mice"],"prefix":"10.1158","volume":"69","author":[{"given":"Bokyung","family":"Sung","sequence":"first","affiliation":[{"name":"1Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Murakami","sequence":"additional","affiliation":[{"name":"2Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babatunde O.","family":"Oyajobi","sequence":"additional","affiliation":[{"name":"3Department of Cellular and Structural Biology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat B.","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"1Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2009,2,12]]},"reference":[{"key":"2022061701380283200_B1","doi-asserted-by":"crossref","unstructured":"Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Genet\u20082003; 4: 638\u201349.","DOI":"10.1038\/nrg1122"},{"key":"2022061701380283200_B2","doi-asserted-by":"crossref","unstructured":"Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature\u20082003; 423: 337\u201342.","DOI":"10.1038\/nature01658"},{"key":"2022061701380283200_B3","doi-asserted-by":"crossref","unstructured":"Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol\u20082003; 3: 745\u201356.","DOI":"10.1038\/nri1184"},{"key":"2022061701380283200_B4","doi-asserted-by":"crossref","unstructured":"Nakashima T, Wada T, Penninger JM. RANKL and RANK as novel therapeutic targets for arthritis. Curr Opin Rheumatol\u20082003; 15: 280\u20137.","DOI":"10.1097\/00002281-200305000-00016"},{"key":"2022061701380283200_B5","doi-asserted-by":"crossref","unstructured":"Romas E, Sims NA, Hards DK, et al. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. Am J Pathol\u20082002; 161: 1419\u201327.","DOI":"10.1016\/S0002-9440(10)64417-3"},{"key":"2022061701380283200_B6","doi-asserted-by":"crossref","unstructured":"Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature\u20081999; 397: 315\u201323.","DOI":"10.1038\/16852"},{"key":"2022061701380283200_B7","doi-asserted-by":"crossref","unstructured":"Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell\u20081997; 89: 309\u201319.","DOI":"10.1016\/S0092-8674(00)80209-3"},{"key":"2022061701380283200_B8","doi-asserted-by":"crossref","unstructured":"Roodman GD. Mechanisms of bone metastasis. N Engl J Med\u20082004; 350: 1655\u201364.","DOI":"10.1056\/NEJMra030831"},{"key":"2022061701380283200_B9","doi-asserted-by":"crossref","unstructured":"Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer\u20082002; 2: 584\u201393.","DOI":"10.1038\/nrc867"},{"key":"2022061701380283200_B10","doi-asserted-by":"crossref","unstructured":"Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM. Mechanisms of TNF-\u03b1- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest\u20082003; 111: 821\u201331.","DOI":"10.1172\/JCI200316069"},{"key":"2022061701380283200_B11","doi-asserted-by":"crossref","unstructured":"Assuma R, Oates T, Cochran D, Amar S, Graves DT. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol\u20081998; 160: 403\u20139.","DOI":"10.4049\/jimmunol.160.1.403"},{"key":"2022061701380283200_B12","doi-asserted-by":"crossref","unstructured":"Berenson JR. Advances in the biology and treatment of myeloma bone disease. Semin Oncol\u20082002; 29: 11\u20136.","DOI":"10.1016\/S0093-7754(02)70055-9"},{"key":"2022061701380283200_B13","doi-asserted-by":"crossref","unstructured":"Tanaka T, Shimizu M, Kohno H, et al. Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet. Life Sci\u20082001; 69: 1935\u201345.","DOI":"10.1016\/S0024-3205(01)01277-2"},{"key":"2022061701380283200_B14","doi-asserted-by":"crossref","unstructured":"Murakami A, Hayashi R, Tanaka T, Kwon KH, Ohigashi H, Safitri R. Suppression of dextran sodium sulfate-induced colitis in mice by zerumbone, a subtropical ginger sesquiterpene, and nimesulide: separately and in combination. Biochem Pharmacol\u20082003; 66: 1253\u201361.","DOI":"10.1016\/S0006-2952(03)00446-5"},{"key":"2022061701380283200_B15","doi-asserted-by":"crossref","unstructured":"Murakami A, Tanaka T, Lee JY, et al. Zerumbone, a sesquiterpene in subtropical ginger, suppresses skin tumor initiation and promotion stages in ICR mice. Int J Cancer\u20082004; 110: 481\u201390.","DOI":"10.1002\/ijc.20175"},{"key":"2022061701380283200_B16","doi-asserted-by":"crossref","unstructured":"Huang GC, Chien TY, Chen LG, Wang CC. Antitumor effects of zerumbone from Zingiber zerumbet in P-388D1 cells in vitro and in vivo. Planta Med\u20082005; 71: 219\u201324.","DOI":"10.1055\/s-2005-837820"},{"key":"2022061701380283200_B17","doi-asserted-by":"crossref","unstructured":"Szabolcs A, Tiszlavicz L, Kaszaki J, et al. Zerumbone exerts a beneficial effect on inflammatory parameters of cholecystokinin octapeptide-induced experimental pancreatitis but fails to improve histology. Pancreas\u20082007; 35: 249\u201355.","DOI":"10.1097\/mpa.0b013e318070d791"},{"key":"2022061701380283200_B18","doi-asserted-by":"crossref","unstructured":"Takada Y, Murakami A, Aggarwal BB. Zerumbone abolishes NF-\u03baB and I\u03baB\u03b1 kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion. Oncogene\u20082005; 24: 6957\u201369.","DOI":"10.1038\/sj.onc.1208845"},{"key":"2022061701380283200_B19","doi-asserted-by":"crossref","unstructured":"Murakami A, Takahashi M, Jiwajinda S, Koshimizu K, Ohigashi H. Identification of zerumbone in Zingiber zerumbet Smith as a potent inhibitor of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation. Biosci Biotechnol Biochem\u20081999; 63: 1811\u20132.","DOI":"10.1271\/bbb.63.1811"},{"key":"2022061701380283200_B20","doi-asserted-by":"crossref","unstructured":"Hsu H, Lacey DL, Dunstan CR, et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A\u20081999; 96: 3540\u20135.","DOI":"10.1073\/pnas.96.7.3540"},{"key":"2022061701380283200_B21","doi-asserted-by":"crossref","unstructured":"Wei S, Teitelbaum SL, Wang MW, Ross FP. Receptor activator of nuclear factor-\u03baB ligand activates nuclear factor-\u03baB in osteoclast precursors. Endocrinology\u20082001; 142: 1290\u20135.","DOI":"10.1210\/endo.142.3.8031"},{"key":"2022061701380283200_B22","doi-asserted-by":"crossref","unstructured":"Sung B, Pandey MK, Aggarwal BB. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-\u03baB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated I\u03baB\u03b1 kinase activation. Mol Pharmacol\u20082007; 71: 1703\u201314.","DOI":"10.1124\/mol.107.034512"},{"key":"2022061701380283200_B23","unstructured":"Oyajobi BO, Anderson DM, Traianedes K, Williams PJ, Yoneda T, Mundy GR. Therapeutic efficacy of a soluble receptor activator of nuclear factor \u03baB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy. Cancer Res\u20082001; 61: 2572\u20138."},{"key":"2022061701380283200_B24","doi-asserted-by":"crossref","unstructured":"Kobayashi Y, Mizoguchi T, Take I, Kurihara S, Udagawa N, Takahashi N. Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1. J Biol Chem\u20082005; 280: 11395\u2013403.","DOI":"10.1074\/jbc.M411189200"},{"key":"2022061701380283200_B25","doi-asserted-by":"crossref","unstructured":"Ghosh S, Karin M. Missing pieces in the NF-\u03baB puzzle. Cell\u20082002; 109 Suppl: S81\u201396.","DOI":"10.1016\/S0092-8674(02)00703-1"},{"key":"2022061701380283200_B26","doi-asserted-by":"crossref","unstructured":"Chikatsu N, Takeuchi Y, Tamura Y, et al. Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro. Biochem Biophys Res Commun\u20082000; 267: 632\u20137.","DOI":"10.1006\/bbrc.1999.2008"},{"key":"2022061701380283200_B27","doi-asserted-by":"crossref","unstructured":"Lai FP, Cole-Sinclair M, Cheng WJ, et al. Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation. Br J Haematol\u20082004; 126: 192\u2013201.","DOI":"10.1111\/j.1365-2141.2004.05018.x"},{"key":"2022061701380283200_B28","doi-asserted-by":"crossref","unstructured":"Park BK, Zhang H, Zeng Q, et al. NF-\u03baB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med\u20082007; 13: 62\u20139.","DOI":"10.1038\/nm1519"},{"key":"2022061701380283200_B29","doi-asserted-by":"crossref","unstructured":"Uhlik M, Good L, Xiao G, et al. NF-\u03baB-inducing kinase and I\u03baB kinase participate in human T-cell leukemia virus I Tax-mediated NF-\u03baB activation. J Biol Chem\u20081998; 273: 21132\u20136.","DOI":"10.1074\/jbc.273.33.21132"},{"key":"2022061701380283200_B30","doi-asserted-by":"crossref","unstructured":"Novack DV, Yin L, Hagen-Stapleton A, et al. The I\u03baB function of NF-\u03baB2 p100 controls stimulated osteoclastogenesis. J Exp Med\u20082003; 198: 771\u201381.","DOI":"10.1084\/jem.20030116"},{"key":"2022061701380283200_B31","doi-asserted-by":"crossref","unstructured":"Dai S, Hirayama T, Abbas S, Abu-Amer Y. The I\u03baB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J Biol Chem\u20082004; 279: 37219\u201322.","DOI":"10.1074\/jbc.C400258200"},{"key":"2022061701380283200_B32","doi-asserted-by":"crossref","unstructured":"Aggarwal BB. Nuclear factor-\u03baB: the enemy within. Cancer Cell\u20082004; 6: 203\u20138.","DOI":"10.1016\/j.ccr.2004.09.003"},{"key":"2022061701380283200_B33","doi-asserted-by":"crossref","unstructured":"Zheng H, Yu X, Collin-Osdoby P, Osdoby P. RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-\u03b2 via NF-\u03baB that restrains osteoclastogenesis and bone resorption. J Biol Chem\u20082006; 281: 15809\u201320.","DOI":"10.1074\/jbc.M513225200"},{"key":"2022061701380283200_B34","doi-asserted-by":"crossref","unstructured":"Franzoso G, Carlson L, Xing L, et al. Requirement for NF-\u03baB in osteoclast and B-cell development. Genes Dev\u20081997; 11: 3482\u201396.","DOI":"10.1101\/gad.11.24.3482"},{"key":"2022061701380283200_B35","doi-asserted-by":"crossref","unstructured":"Abu-Amer Y, Dowdy SF, Ross FP, Clohisy JC, Teitelbaum SL. TAT fusion proteins containing tyrosine 42-deleted I\u03baB\u03b1 arrest osteoclastogenesis. J Biol Chem\u20082001; 276: 30499\u2013503.","DOI":"10.1074\/jbc.M104725200"},{"key":"2022061701380283200_B36","doi-asserted-by":"crossref","unstructured":"Clohisy JC, Roy BC, Biondo C, et al. Direct inhibition of NF-\u03baB blocks bone erosion associated with inflammatory arthritis. J Immunol\u20082003; 171: 5547\u201353.","DOI":"10.4049\/jimmunol.171.10.5547"},{"key":"2022061701380283200_B37","doi-asserted-by":"crossref","unstructured":"Carlin BI, Andriole GL. The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma. Cancer\u20082000; 88: 2989\u201394.","DOI":"10.1002\/1097-0142(20000615)88:12+<2989::AID-CNCR14>3.0.CO;2-Q"},{"key":"2022061701380283200_B38","doi-asserted-by":"crossref","unstructured":"Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev\u20082001; 27: 165\u201376.","DOI":"10.1053\/ctrv.2000.0210"},{"key":"2022061701380283200_B39","doi-asserted-by":"crossref","unstructured":"Bhatia P, Sanders MM, Hansen MF. Expression of receptor activator of nuclear factor-\u03baB is inversely correlated with metastatic phenotype in breast carcinoma. Clin Cancer Res\u20082005; 11: 162\u20135.","DOI":"10.1158\/1078-0432.162.11.1"},{"key":"2022061701380283200_B40","doi-asserted-by":"crossref","unstructured":"Bharti AC, Shishodia S, Reuben JM, et al. Nuclear factor-\u03baB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. Blood\u20082004; 103: 3175\u201384.","DOI":"10.1182\/blood-2003-06-2151"},{"key":"2022061701380283200_B41","doi-asserted-by":"crossref","unstructured":"Biswas DK, Shi Q, Baily S, et al. NF-\u03baB activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci U S A\u20082004; 101: 10137\u201342.","DOI":"10.1073\/pnas.0403621101"},{"key":"2022061701380283200_B42","doi-asserted-by":"crossref","unstructured":"Lipton A. Biochemical bone markers in breast cancer. Cancer Treat Rev\u20082006; 32 Suppl 1: 20\u20132.","DOI":"10.1016\/S0305-7372(06)80005-8"},{"key":"2022061701380283200_B43","doi-asserted-by":"crossref","unstructured":"Cartsos VM, Zhu S, Zavras AI. Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people. J Am Dent Assoc\u20082008; 139: 23\u201330.","DOI":"10.14219\/jada.archive.2008.0016"},{"key":"2022061701380283200_B44","doi-asserted-by":"crossref","unstructured":"Mariotti A. Bisphosphonates and osteonecrosis of the jaws. J Dent Educ\u20082008; 72: 919\u201329.","DOI":"10.1002\/j.0022-0337.2008.72.8.tb04568.x"},{"key":"2022061701380283200_B45","doi-asserted-by":"crossref","unstructured":"Hoff AO, Toth BB, Altundag K, et al. Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res\u20082008; 23: 826\u201336.","DOI":"10.1359\/jbmr.080205"},{"key":"2022061701380283200_B46","doi-asserted-by":"crossref","unstructured":"Gevorgyan A, Enepekides DJ. Bisphosphonate-induced necrosis of the jaws: a reconstructive nightmare. Curr Opin Otolaryngol Head Neck Surg\u20082008; 16: 325\u201330.","DOI":"10.1097\/MOO.0b013e328304b445"},{"key":"2022061701380283200_B47","doi-asserted-by":"crossref","unstructured":"Body JJ, Facon T, Coleman RE, et al. A study of the biological receptor activator of nuclear factor-\u03baB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer. Clin Cancer Res\u20082006; 12: 1221\u20138.","DOI":"10.1158\/1078-0432.CCR-05-1933"},{"key":"2022061701380283200_B48","doi-asserted-by":"crossref","unstructured":"Hunt NC, Fujikawa Y, Sabokbar A, Itonaga I, Harris A, Athanasou NA. Cellular mechanisms of bone resorption in breast carcinoma. Br J Cancer\u20082001; 85: 78\u201384.","DOI":"10.1054\/bjoc.2001.1856"},{"key":"2022061701380283200_B49","doi-asserted-by":"crossref","unstructured":"Tada T, Jimi E, Okamoto M, Ozeki S, Okabe K. Oral squamous cell carcinoma cells induce osteoclast differentiation by suppression of osteoprotegerin expression in osteoblasts. Int J Cancer\u20082005; 116: 253\u201362.","DOI":"10.1002\/ijc.21008"}],"updated-by":[{"DOI":"10.1158\/0008-5472.can-18-1827","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"record-id":"19134"},{"DOI":"10.1158\/0008-5472.can-18-1827","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000}}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/4\/1477\/2621977\/1477.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/4\/1477\/2621977\/1477.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T17:24:04Z","timestamp":1684862644000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/4\/1477\/552878\/Zerumbone-Abolishes-RANKL-Induced-NF-B-Activation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,12]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,2,12]]},"published-print":{"date-parts":[[2009,2,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-3249","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6499776","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381170.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499776.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381170","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381173.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381173","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,12]]}}}